KIAA1429 promotes vascular smooth muscle cell PANoptosis via m6A-dependent PIEZO1/NLRP3 activation in lower extremity arteriosclerosis obliterans
Objective Arteriosclerosis obliterans (ASO) involves vascular smooth muscle cell (VSMC) dysfunction, cell death, and vascular inflammation. This study investigated the role of the m 6 A writer KIAA1429 and its downstream mechanosensitive signaling in ASO pathogenesis. Methods Human VSMCs (hVSMCs) were treated with ox-LDL to establish an ASO-like cellular injury model and subjected to KIAA1429 overexpression or knockdown, with Yoda1 used as a PIEZO1 agonist. A candidate PIEZO1 m 6 A site was evaluated using wild-type (WT) and site-mutant (Mut) dual-luciferase reporters together with Actinomycin D decay analysis. Reverse genetic rescue combined KIAA1429 overexpression with PIEZO1 silencing, followed by lipid staining, flow cytometry, cytokine ELISA, NLRP3-ASC co-immunoprecipitation (Co-IP), and profiling of pyroptosis-, apoptosis-, and necroptosis-associated proteins. An in vivo ASO model was established in ApoE - / - mice by high-fat feeding and femoral artery ligation, with SM22α-driven AAV-shKIAA1429 used for VSMC-associated KIAA1429 knockdown; serum cytokines and α-SMA-based arterial immunofluorescence were subsequently analyzed. Results In vitro , ox-LDL significantly upregulated KIAA1429 expression and total m 6 A levels. RIP-qPCR demonstrated an association between KIAA1429 and PIEZO1 mRNA, and KIAA1429 overexpression prolonged PIEZO1 mRNA half-life. KIAA1429 overexpression increased WT PIEZO1 reporter activity and stability, whereas mutation of the candidate m 6 A adenosine markedly blunted this response. PIEZO1 silencing attenuated KIAA1429-overexpression-induced lipid accumulation, apoptosis, IL-1β/IL-18 release, NLRP3-ASC association, and activation of pyroptosis-, apoptosis-, and necroptosis-associated proteins. In vivo , SM22α-mediated KIAA1429 silencing attenuated vascular thickening, lipid deposition, and fibrosis, reduced serum IL-1β/IL-18, and decreased KIAA1429 and PIEZO1 signals within α-SMA-positive arterial regions. Conclusions KIAA1429 exacerbates ASO-associated vascular injury by promoting candidate-site-sensitive m 6 A-associated stabilization of PIEZO1 mRNA, thereby enhancing PIEZO1/NLRP3 signaling and coordinated VSMC inflammatory cell-death programs. The KIAA1429/PIEZO1/NLRP3 axis therefore represents a mechanistically supported candidate target for further ASO investigation.
Authors
- Ying Lan (ORCID: https://orcid.org/0000-0001-7651-1753)
- Chongbin Zhou
- Shaohong Yin
- Erdemutu E.
- Liqiang Hu
Institutions
- Hohhot First Hospital (CN)
- Inner Mongolia Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3389/fimmu.2026.1896821
- Primary Topic
- Atherosclerosis and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00